GlassScriptPhysician profile
Roger Hill Emerson
NPI 1215972559
$691,450.89
in general payments reported to CMS, 2019-2025
19 companies · $517 in 2025
The $517 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $243K · 2020: $213K · 2021: $176K · 2022: $52K · 2023: $6,419 · 2024: $344 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,000 · Food and Beverage: $1,279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,000.00 |
| Food and Beverage | $1,279.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $689,579.58 | 2019-2025 | Comprehensive Shoulder System, Gps III Platelet Concentration System |
| Bone Support INC. | $367.96 | 2020-2021 | |
| Shalby Advanced Technologies, INC. | $324.45 | 2023 | |
| Merge Healthcare Incorporated | $228.00 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $217.20 | 2019-2025 | Zilretta, Iovera |
| Becton, Dickinson and Company | $169.40 | 2024-2025 | Surgiphor |
| Ferring Pharmaceuticals INC. | $121.51 | 2022-2024 | Euflexxa |
| Bioventus LLC | $75.82 | 2024-2025 | Durolane |
| Depuy Synthes Sales INC. | $63.00 | 2022-2025 | Monovisc, Orthovisc |
| Medacta USA, INC. | $59.00 | 2023 | Gmk Sphere |
| Vertex Pharmaceuticals Incorporated | $51.88 | 2024-2025 | |
| Pacira Therapeutics, INC. | $51.25 | 2019-2020 | |
| Davol INC. | $46.91 | 2025 | Arista |
| Stryker Corporation | $28.81 | 2020 | |
| Next Science LLC | $22.82 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $19.90 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Solventum Corporation | $18.90 | 2025 | Prevena |
| Salvin Dental Specialties, INC. | $2.50 | 2021 | |
| Endotronix, INC. | $2.00 | 2024 | Cordella Pulomonary Artery Pressure Sensor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Emerson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.